乳腺病理诊断不一致与错误:原因、分类及医疗法律意义
本文综述乳腺病理诊断中观察者间变异、诊断错误与医疗过失的区分,强调错误多源于系统脆弱性而非个人表现,并推荐结构化报告、质量控制、多学科协作等措施以降低诊断风险。
要点
- 观察者间变异在交界性病变中属可接受的职业差异,非错误或过失。
- 诊断错误可发生于分析前、中、后各阶段,常反映系统漏洞。
- 推荐结构化报告、质控参与、多学科团队协作及实验室认证。
核心结论
- 乳腺病理中观察者间变异应视为可接受的职业差异,而非诊断错误或过失。
- 诊断错误常反映系统脆弱性,如工作流程低效、质量控制不足或活检采样有限。
研究设计与样本
- 综述,未报告检索范围与样本量。
主要发现
- 观察者间变异在交界性病变(如叶状肿瘤分级)和重叠病变(如非典型大汗腺病变)中已被公认。
- 错误可发生于分析前、分析中或分析后阶段,源于标本错误识别、污染或丢失、采样不足或文档不完整。
关键数值与推荐
- 推荐结构化报告、对复杂病例保持警惕、参与质量保证、明确记录不确定性、积极参与多学科团队及实验室认证。
临床怎么用
- 临床应区分可接受的观察者间变异与真正的诊断错误,避免过度归责。
- 通过结构化报告和明确记录不确定性来降低诊断风险并提高医疗法律可辩护性。
局限性
- 本文为综述,未报告系统检索策略、纳入研究数量及偏倚评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnostic pathology is inherently interpretative and subject to interobserver variability. Although diagnostic concordance is a critical quality metric, distinguishing between acceptable variation, diagnostic error, and professional negligence is essential for both clinical care and medicolegal clarity. This review highlights the difference between interobserver variability (diagnostic disagreement/discordance) that remains within acceptable professional limits, diagnostic error (a deviation from expected standards due to cognitive, technical, or systemic factors), and negligence (a repeated, reckless, or unjustified deviation from established standards). Errors in pathology often reflect systemic vulnerabilities, such as workflow inefficiencies, inadequate quality control, or limited biopsy sampling, rather than individual performance alone. They may occur at any stage of the diagnostic pathway (preanalytical, analytical, or postanalytical) and arise from specimen misidentification, contamination or loss, inadequate sampling, or incomplete documentation. Pathologist-related errors encompass failure to recognize significant pathology, misinterpretation, omission of appropriate ancillary studies, insufficient workup of complex cases, including failure to seek a second opinion, or substandard reporting. Medicolegal implications are heightened when such errors result in delayed diagnosis or major misclassification, leading to patient harm. In breast pathology, interobserver variation in the classification of borderline lesions (eg, grading of phyllodes tumors) and in the interpretation of overlapping entities (eg, atypical apocrine lesions) is well recognized. Although such differences may influence management, they should be regarded as acceptable professional variability, rather than error or negligence. To minimize diagnostic risk and uphold standards, structured reporting, vigilance in complex cases, participation in quality assurance, explicit documentation of uncertainty, active multidisciplinary team engagement, and laboratory accreditation are strongly recommended. Supporting pathologists as diagnosticians and patient safety advocates, within a culture of openness, shared learning, and institutional support, remains central to diagnostic accuracy, transparency, and medicolegal defensibility.
引用
- Rakha EA, Quinn CM, Provenzano E, et al. Diagnostic Discordance and Error in Breast Pathology: Causes, Classifications, and Medicolegal Implications. Mod Pathol. 2025. PMID: 41285251. doi:10.1016/j.modpat.2025.100942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。